Target Details
| UniProt AC | Q14164 |
|---|---|
| Gene Symbol | IKBKE |
| Protein Name | Inhibitor of nuclear factor kappa-B kinase subunit epsilon |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) PF18394 (TBK1_CCD1) PF18396 (TBK1_ULD) |
Summary
- Multi-target molecules 596
- Clinical molecules 14
- Avg pChEMBL 7.38
KEGG Pathways (18)
- Alcoholic liver disease
- C-type lectin receptor signaling pathway
- Chemical carcinogenesis - receptor activation
- Coronavirus disease - COVID-19
- Cytosolic DNA-sensing pathway
- Epstein-Barr virus infection
- Hepatitis B
- Hepatitis C
- Herpes simplex virus 1 infection
- Human papillomavirus infection
- IL-17 signaling pathway
- Influenza A
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- NOD-like receptor signaling pathway
- RIG-I-like receptor signaling pathway
- Toll-like receptor signaling pathway
Active Molecules (596)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
CMIDPQPFFSHFQU
|
8.5 | IC50 | 3 | — | |
DBRHWHXJDUTFKP
|
8.5 | IC50 | 3 | — | |
FKKXZTUVHWKAQM
|
8.5 | IC50 | 3 | — | |
GFUQWWAFJKBDPB
|
8.5 | IC50 | 3 | — | |
GFUZNXPSFSEACI
|
8.5 | IC50 | 3 | — | |
HZCTUVOMFAAAFJ
|
8.5 | IC50 | 3 | — | |
NOENZZUCTRZYIH
|
8.5 | IC50 | 3 | — | |
OTUJIVCCULIMCW
|
8.5 | IC50 | 2 | — | |
SRIFSUWDDPLONW
|
8.5 | IC50 | 3 | — | |
VEMSSQHOLIBJEZ
|
8.5 | IC50 | 3 | — | |
VFYVJNXWRBZRHQ
|
8.5 | IC50 | 3 | — | |
ZYXAFPZQDYBFBQ
|
8.5 | IC50 | 3 | — | |
ABZIEHMTFVZXNY
|
8.5 | IC50 | 2 | — | |
HXICXBITQYMWNF
|
8.5 | IC50 | 2 | — | |
IAHBPEPPERDPHA
|
8.5 | IC50 | 2 | — | |
XNQOGRKQAFZETL
|
8.4 | IC50 | 2 | — | |
BCWYUBHSQSCBFH
|
8.4 | IC50 | 2 | — | |
CMQXQMALEDSQQH
|
8.4 | IC50 | 2 | — | |
FNPIJCTUNTWVDI
|
8.4 | IC50 | 2 | — | |
GCHKGFCTYIRHHF
|
8.4 | IC50 | 3 | — | |
IXEXMSDQIVNECG
|
8.4 | IC50 | 3 | — | |
MQZYHFYFOXLRBV
|
8.4 | IC50 | 2 | — | |
NKOHMDYLNLLENR
|
8.4 | IC50 | 2 | — | |
QLUFGSNYFKCBJT
|
8.4 | IC50 | 3 | — | |
SVGGQHQGUDVYQO
|
8.4 | IC50 | 3 | — | |
VOOUPXYOOCEEFC
|
8.4 | IC50 | 3 | — | |
XGJGUJSSRHZXEN
|
8.4 | IC50 | 3 | — | |
YKBZGTPZXATTES
|
8.4 | IC50 | 3 | — | |
ZFQFDCSTGATGQP
|
8.4 | IC50 | 4 | — | |
OYYIEVDIWZMYFO
|
8.4 | IC50 | 2 | — | |
GMCWMRVYPOUFAZ
|
8.4 | IC50 | 2 | — | |
OKCGDSORGJQEJP
|
8.4 | IC50 | 2 | — | |
WKOPXZJZJXUFCH
|
8.4 | IC50 | 2 | — | |
WKVLVOVZAQKAFP
|
8.3 | IC50 | 2 | — | |
AYYWOVUIQSBYDE
|
8.3 | IC50 | 3 | — | |
LDRHKGHHXJWLJD
|
8.3 | IC50 | 2 | — | |
VMYWSKHQGSIDJS
|
8.3 | IC50 | 2 | — | |
BMLBSNHUAPOBHI
|
8.3 | IC50 | 2 | — | |
BTKYEHNXCFJUHN
|
8.3 | IC50 | 2 | — | |
CCLSCLZBGDZBMU
|
8.3 | IC50 | 3 | — | |
CCNUFZSUSDCFGN
|
8.3 | IC50 | 3 | — | |
CIBVSEISWWXHEO
|
8.3 | IC50 | 2 | — | |
CQFQKMKEBSPJGU
|
8.3 | IC50 | 3 | — | |
GJFXOWOMEQKLPP
|
8.3 | IC50 | 3 | — | |
GWPLDWSTEUIHCJ
|
8.3 | IC50 | 3 | — | |
HKSZLNNOFSGOKW
|
8.3 | Ki | 118 | — | |
KRCXSXIRZJARBO
|
8.3 | IC50 | 3 | — | |
MHRJILLQTVZIBV
|
8.3 | IC50 | 3 | — | |
OUYJBEHLMYTWDO
|
8.3 | IC50 | 3 | — | |
PZTKSZRHTHXHMA
|
8.3 | IC50 | 3 | — |